Associate Director, Tax
Cytokinetics
Summary
Cytokinetics is a specialty cardiovascular biopharmaceutical company advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. The Associate Director, Tax serves as a key business partner to the Senior Director, Tax and supports the implementation and execution of the company's global tax strategy, with broad exposure across tax provision, global compliance oversight, transfer pricing, tax controversy, M&A support, tax technology, and international tax matters.
Job description
Key Responsibilities
Tax Provision, Reporting, and Controls
- Oversee the global income tax accounting and reporting process under ASC 740.
- Manage external tax provision preparers to ensure timely and accurate quarterly and annual tax reporting.
- Review and oversee effective tax rate analyses, uncertain tax positions, tax disclosures, and supporting documentation.
- Maintain and enhance SOX controls and governance processes related to income tax accounting and reporting.
- Drive process improvements to increase efficiency, accuracy, and transparency in tax reporting.
- Coordinate closely with Corporate Accounting, Internal Audit, and External Auditors.
Global Tax Compliance Oversight
- Provide oversight of global direct and indirect tax compliance activities across all jurisdictions.
- Manage external service providers and internal stakeholders responsible for preparation and filing activities.
- Ensure tax returns, elections, and payments are completed accurately and on a timely basis.
- Maintain appropriate controls, governance, and monitoring processes over global compliance activities.
- Identify opportunities to improve compliance processes and reduce operational risk.
Transfer Pricing
- Oversee global transfer pricing compliance and documentation requirements.
- Manage relationships with external transfer pricing advisors and consultants.
- Monitor implementation of transfer pricing policies across the organization.
- Support the Senior Director, Tax in evaluating and developing transfer pricing planning opportunities.
- Partner with Finance, Legal, and business stakeholders to ensure alignment between transfer pricing policies and operational activities.
Tax Technology and Process Improvement
- Drive modernization and automation initiatives within the tax function.
- Help develop tax data, reporting, and technology strategies.
- Improve tax process efficiency through enhanced controls, analytics, and digital tools.
- Support implementation and optimization of tax technology solutions.
Tax Controversy, Risk Management, and Special Projects
- As needed, manage tax audits, inquiries, examinations, and disputes with tax authorities globally.
- Coordinate responses to regulatory information requests and audit activities.
- Identify emerging tax risks and develop mitigation strategies in partnership with the Senior Director, Tax.
- Lead and support ad hoc tax projects, business development, technical analyses, and cross-functional initiatives as business needs arise.
Business Partnership and Global Tax Strategy Support
- Support implementation and execution of the company's global tax strategy in alignment with business objectives.
- Partner with business leaders, Finance, Legal, Commercial, Supply Chain, and other stakeholders to evaluate tax implications of key business decisions.
- Assist with evaluating tax implications of business reorganizations, supply chain changes, licensing arrangements, and financing transactions.
- Lead analysis related to Pillar Two, BEPS developments, and other international tax initiatives.
Qualifications
Education: Bachelor's degree in Accounting, Finance, Tax, or related field. CPA, JD/LLM (Taxation), or equivalent professional qualification preferred.
Experience: 8+ years of progressive tax experience. Combination of Big Four/public accounting and multinational corporate tax experience strongly preferred. Significant experience in tax provision, international tax, tax planning, and tax controversy. Experience supporting a global organization with operations in multiple jurisdictions. Pharmaceutical, life sciences, biotechnology, or healthcare industry experience preferred. Experience with Pillar Two implementation and global tax reform initiatives preferred.
Technical Skills: Strong knowledge of U.S. and international corporate taxation. Deep understanding of ASC 740 and tax accounting principles. Familiarity with transfer pricing regulations and OECD guidelines. Knowledge of global tax compliance frameworks and risk management practices. Experience with tax technology and ERP systems (e.g., SAP, Oracle).
Requirements
- Bachelor's degree in Accounting, Finance, Tax, or related field
- 8+ years of progressive tax experience
- Significant experience in tax provision, international tax, tax planning, and tax controversy
- Experience supporting a global organization with operations in multiple jurisdictions
- Strong knowledge of U.S. and international corporate taxation
- Deep understanding of ASC 740 and tax accounting principles
- Familiarity with transfer pricing regulations and OECD guidelines
- Knowledge of global tax compliance frameworks and risk management practices
- Experience with tax technology and ERP systems (e.g., SAP, Oracle)
- CPA, JD/LLM (Taxation), or equivalent professional qualification preferred
- Combination of Big Four/public accounting and multinational corporate tax experience strongly preferred
- Pharmaceutical, life sciences, biotechnology, or healthcare industry experience preferred
- Experience with Pillar Two implementation and global tax reform initiatives preferred
Benefits
- Stock Options
- Restricted Stock Units
- Medical, Dental & Vision
- Life & Disability Insurance
- 401(k) Matching
- Learning Stipends
- Wellness Stipends
- Paid Time Off
Company overview
Cytokinetics, Incorporated is a late-stage biopharmaceutical company headquartered in South San Francisco, California, specializing in muscle biology research and drug development. Founded in 1997 by leading scientists from Stanford, UCSD, and UCSF, the company focuses on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors for debilitating diseases characterized by impaired or declining muscle function. With over 25 years of scientific expertise, Cytokinetics has built a robust pipeline targeting cardiovascular and neuromuscular conditions including heart failure, hypertrophic cardiomyopathy, and amyotrophic lateral sclerosis (ALS). The company's innovative approach centers on directly targeting the sarcomere, the fundamental unit of muscle contraction, to develop potential treatments that may preserve and extend independence for patients. Cytokinetics operates as a publicly traded company (NASDAQ: CYTK) and has established itself as a leader in muscle biology with more than 115 publications, over 100 clinical trials, and hundreds of issued patents.